AJ Lanigan: Indeed. Actually, Pharma companies are generating big money with treatments like Keytruda and Opdivo that deal with PD-1 and PD-L1. In this article’s the super great part: think about checkpoints as traffic signals. You don’t want an immune system that’s managing wild just like a freight teach around waiting for link from Social Bookmarking (2)